Physician profile
William K Pope
NPI 1588744973
$2,162.14
in general payments reported to CMS, 2019-2025
14 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $142 · 2021: $161 · 2022: $246 · 2023: $92.14 · 2024: $263 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,210.84 | 2019-2025 | Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $145.34 | 2019-2021 | |
| Ocular Therapeutix, INC. | $138.07 | 2024 | Dextenza |
| Abbvie INC. | $137.57 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $124.99 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $122.69 | 2022-2023 | Infuse |
| Johnson & Johnson Vision Care, INC. | $63.23 | 2020-2023 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $57.65 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $39.64 | 2020 | |
| Shire North American Group INC | $37.05 | 2019 | |
| Coopervision INC. | $26.03 | 2020 | |
| Sun Pharmaceutical Industries INC. | $25.41 | 2022 | |
| Oyster Point Pharma, INC. | $18.48 | 2022 | |
| Sight Sciences, INC. | $15.15 | 2025 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.